MOXAM Drug Patent Profile
✉ Email this page to a colleague
When do Moxam patents expire, and what generic alternatives are available?
Moxam is a drug marketed by Lilly and is included in one NDA.
The generic ingredient in MOXAM is moxalactam disodium. There is one drug master file entry for this compound. Additional details are available on the moxalactam disodium profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for MOXAM?
- What are the global sales for MOXAM?
- What is Average Wholesale Price for MOXAM?
Summary for MOXAM
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 68 |
| Patent Applications: | 4,178 |
| DailyMed Link: | MOXAM at DailyMed |
US Patents and Regulatory Information for MOXAM
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lilly | MOXAM | moxalactam disodium | INJECTABLE;INJECTION | 050550-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Lilly | MOXAM | moxalactam disodium | INJECTABLE;INJECTION | 050550-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Lilly | MOXAM | moxalactam disodium | INJECTABLE;INJECTION | 050550-004 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
